Wei Cao

TL;DR: A 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covod-19 who were also seen in the same intensive care unit are described.

TL;DR: The immunological changes of coronaviruses like SARS, MERS and other viral pneumonia similar to SARS-CoV-2 are reviewed and the potential pathogenesis of COVID-19 is inferred, and the treatment recommendations for giving high-doses intravenous immunoglobulin and low-molecular-weight heparin anticoagulant therapy to severe type patients are proposed.

TL;DR: Results from 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery suggest randomized studies of high- dose IVIg should be considered in deteriorating patients infected with CO VID-19.

TL;DR: The existence of hypercoagulation status in critical COVID-2019 patients with acro-ischemia should be monitored closely, and anticoagulation therapy can be considered in selected patients.

TL;DR: Findings from this small group of cases suggest that no SARS-CoV-2 virus existing in the vaginal fluids of severe COVID-19 patients is suggested.